Abstract
To elucidate the synergistic effects of taurine and l-arginine on hypertension, 25% fructose were administered to male Wistar rats for 3 months to establish insulin resistance hypertensive models. Rats with the systolic blood pressure (SBP) higher than 150 mmHg were considered as model rats. Forty-two model rats were randomly divided into six groups and administered with 3% taurine, 2.7% taurine + 0.3% l-arginine, 2.1% taurine + 0.9% l-arginine, 1.5% taurine + 1.5% l-arginine and 3% l-arginine in drinking water respectively. The results showed that coadministration of taurine (1.5%) and l-arginine (1.5%) could bring the levels of SBP, blood glucose, and insulin down to normal levels after 4 weeks. The thickness of blood vessels increased significantly in model group, which could be reversed by taurine and l-arginine. Serum NO, cGMP, and ET levels could return to normal levels. These data indicated that both taurine and l-arginine could ameliorate vascular remodeling and showed obvious antihypertensive effects, and taurine (1.5%) and l-arginine (1.5%) in the drinking water showed a better result in the cure of hypertension.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- SBP:
-
Systolic blood pressure
- Ins:
-
Insulin
- ET:
-
Endothelin
- cGMP:
-
Cyclic guanosine monophosphate
References
Anuradha CV, Balakrishnan SD (1999) Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance. Can J Physiol Pharmacol 77:749–754
Gokce N (2004) L-arginine and hypertension. J Nutr 134(10 Suppl):2807S–2811S, discussion 2818S-2819S
Harada H, Tsu**o T, Watari Y, Nonaka H, Emoto N, Yokoyama M (2004) Oral taurine supplementation prevents fructose-induced hypertension in rats. Heart Vessels 19(3):132–136
Hagar HH, El Etter E, Arafa M (2006) Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol Physiol 33(3):189–196
Hu J, Xu X, Yang J, Wu G, Sun C, Lv Q (2009) Antihypertensive effect of taurine in rat. Adv Exp Med Biol 643:75–84
Kapakos G, Bouallegue A, Daou GB, Srivastava AK (2010) Modulatory role of nitric oxide/cGMP System in endothelin-1-induced signaling responses in vascular smooth muscle cells. Curr Cardiol Rev 6(4):247–254
Militante JD, Lombardini JB (2002) Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 23(4):381–393
Nakaya Y, Minami A, Harada N et al (2000) Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr 71:54–58
Rahman MM, Park HM, Kim SJ, Go HK, Kim GB, Hong CU, Lee YU, Kim SZ, Kim JS, Kang HS (2011) Taurine prevents hypertension and increases exercise capacity in rats with fructose-induced hypertension. Am J Hypertens 24(5):574–581
Siani A, Pagano E, Iacone R et al (2000) Blood pressure and metabolic changes during dietary L-arginine supplementation in humans. Am J Hypertens 13:547–551
Wascher TC, Graier WF, Dittrich P et al (1997) Effects of low-dose L-arginine on insulin mediated vasodilatation and insulin sensitivity. Eur J Clin Invest 27:690–695
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this paper
Cite this paper
Feng, Y. et al. (2013). Synergistic Effects of Taurine and l-Arginine on Attenuating Insulin Resistance Hypertension. In: El Idrissi, A., L'Amoreaux, W. (eds) Taurine 8. Advances in Experimental Medicine and Biology, vol 775. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6130-2_32
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6130-2_32
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-6129-6
Online ISBN: 978-1-4614-6130-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)